2026 SoLA

[OP2-1] Composite indices of social determinants of health and coronary artery calcium in Korean

[OP2-2] Regional variation in 30-day case fatality after myocardial infarction in Korea, 2003–2023

[OP2-3] Lean metabolic dysfunction-associated steatotic liver disease as an independent predictor of subclinical coronary artery calcification

[OP2-4] Soluble LDL receptor dynamics in the cholesterol and pharmacogenetics study: simvastatin effects and links to lipid metabolism

[OP2-5] Smoking cessation or reduction after myocardial infarction and subsequent risk of cardiovascular events

[MOP2-4-1] Serum phosphate and the progression of arterial stiffness in CKD: from the KNOW-CKD study

[MOP2-4-2] Long-term temporal patterns and regional persistence of district-level obesity, hypertension, and diabetes in Korea, 2008–2024

[MOP2-4-3] Socioeconomic disparities in stroke incidence and case fatality in Korea, 2010–2023

[MOP2-4-4] Single-pill combination vs separate antihypertensive and statin medications and cardiovascular outcomes in young adults

[MOP2-4-5] Socioeconomic disparities in adherence to 24-hour movement guideline and PREVENT–predicted cardiovascular risk: a national survey analysis

[OP3-1] Adiponectin regulates brain endothelial cell function under hyperammonia condition

[OP3-2] TRPC1-mediated calcium dysregulation in cardiac dysfunction and metabolic impairment

[OP3-3] GLP-1 receptor agonist suppresses PDGF-induced VSMC remodeling

[OP3-4] Loss of thyroid hormone receptor beta in myeloid cells promotes atherosclerosis

[OP3-5] Implication of dapagliflozin on endothelial dysfunction by targeting ERK1/2/p90RSK signaling pathway

[OP3-6] Role of ginsenoside Rg2 on angiotensin II-induced phenotypic conversion of vascular smooth muscle cells